Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2023-11-10 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
关于取得专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (791 characters) from Zhejiang Tailin Biotechnology Co., Ltd. about obtaining three patent certificates. It includes details about the patents and states that the patents will not have a major impact on recent operations but will enhance intellectual property protection and innovation. There is no financial data, no mention of financial results, no regulatory certifications, or meeting materials. The document is an official announcement regarding intellectual property achievements, which does not fit into financial report categories like Annual Report, Interim Report, or Earnings Release. It is not a regulatory filing or certification. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2023-11-10 Chinese
上海市锦天城律师事务所关于浙江泰林生物技术股份有限公司2023年第一次临时股东大会的法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and validity of the convening, procedures, attendance, and resolutions passed at the 2023 first extraordinary general meeting (临时股东大会) of Zhejiang Tailin Biotechnology Co., Ltd. It details the verification of the meeting's convening, attendees, voting procedures, and results. The document does not contain financial statements or financial performance data but focuses on the legal compliance and validity of the shareholder meeting and its resolutions. This type of document is a legal proceedings report related to corporate governance and shareholder meetings, not a financial report or announcement of voting results. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length is 4069 characters, which is sufficient for a detailed legal opinion but not a full financial report. It is not a simple announcement or certification, so it is not RNS or RPA. Hence, the classification is LTR with high confidence.
2023-11-06 Chinese
关于向下修正泰林转债转股价格的公告
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding the downward adjustment of the conversion price of its convertible bonds (referred to as 'Tailin Convertible Bonds'). It includes detailed information about the bond issuance, previous adjustments to the conversion price, the regulatory basis for the adjustment, the approval process including board and shareholder meetings, and the final adjusted conversion price effective date. The document is a formal disclosure of a capital structure change related to convertible bonds, specifically the adjustment of the conversion price. It does not contain financial statements or comprehensive financial performance data, nor is it a report or presentation. It is an announcement about a capital change event. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length is 2764 characters, which is consistent with an announcement rather than a full report.
2023-11-06 Chinese
第三届董事会第十九次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of a board meeting resolution by Zhejiang Tailin Biotechnology Co., Ltd. It details the decision to adjust the conversion price of a convertible bond, including meeting attendance, voting results, and references to related regulatory disclosures. There is no financial report or detailed financial data presented, nor is it a report publication announcement. The content focuses on board decisions and corporate governance matters, specifically a board resolution. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is not a report or certification, so it is not RNS or RPA.
2023-11-06 Chinese
2023年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from the 2023 first extraordinary general meeting of shareholders of Zhejiang Tailin Biotechnology Co., Ltd. It details the meeting date, attendance, voting results on several proposals, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the official voting results and resolutions passed at the shareholders meeting. There is no financial data, no presentation materials, no management discussion, and no report publication. The document is clearly an official announcement of voting results from a shareholders meeting, which fits the category 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is short (2143 characters), consistent with a voting results announcement rather than a full report or presentation.
2023-11-06 Chinese
第三届监事会第十四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the Supervisory Board meeting resolution approving the company's 2023 third quarter report. It states that the Supervisory Board reviewed and approved the full third quarter report, but the actual report content is not included here. Instead, it references the full report published on an external website. The document length is short (734 characters) and primarily serves as a formal announcement of the meeting resolution and approval of the report, not the report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as it is a formal disclosure related to regulatory compliance and meeting resolutions, rather than the full Interim/Quarterly Report (IR).
2023-10-26 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.